Monoamine Oxidase Type B Inhibitor [EPC]

Monoamine Oxidase Type B Inhibitor [EPC] was reported 3000 times

Drugs of the Monoamine Oxidase Type B Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 ADRENAL MEDULLA HYPERFUNCTION 1 1.0000
1 DYSKINESIA HYPERPYREXIA SYNDROME 25 0.5319
2 AEROPHOBIA 1 0.1250
3 PARKINSONISM HYPERPYREXIA SYNDROME 18 0.1006
4 NOTHING BY MOUTH ORDER 2 0.0909
5 MEDICAL AID IN DYING 2 0.0833
6 APPLICATION SITE HYPERTROPHY 1 0.0714
7 HERBAL TOXICITY 2 0.0667
8 CATECHOLAMINE CRISIS 2 0.0541
9 DOPAMINE DYSREGULATION SYNDROME 24 0.0538
10 PARKINSONIAN REST TREMOR 9 0.0476
11 HYPOSOMNIA 2 0.0435
12 PARKINSONIAN CRISIS 4 0.0388
13 KLEPTOMANIA 2 0.0274
14 JEALOUS DELUSION 7 0.0247
15 DYSACUSIS 3 0.0242
16 BASAL GANGLIA HAEMATOMA 1 0.0238
17 APPLICATION SITE URTICARIA 42 0.0187
18 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 7 0.0174
19 ACROPHOBIA 1 0.0167
20 APPLICATION SITE BRUISING 1 0.0164
21 HYPERSEXUALITY 28 0.0153
22 CAMPTOCORMIA 3 0.0125
23 ADRENERGIC SYNDROME 1 0.0123
24 NERVE CONDUCTION STUDIES ABNORMAL 2 0.0120
25 APPLICATION SITE MASS 3 0.0109
26 FALSE POSITIVE INVESTIGATION RESULT 11 0.0109
27 IMPULSE-CONTROL DISORDER 22 0.0107
28 BASAL GANGLION DEGENERATION 1 0.0106
29 CATHETER SITE NODULE 2 0.0105
30 APPLICATION SITE REACTION 73 0.0104
31 SPINAL EPIDURAL HAEMATOMA 6 0.0102
32 VOLVULUS OF SMALL BOWEL 2 0.0102
33 BACILLUS TEST POSITIVE 1 0.0101
34 EXCESSIVE MASTURBATION 2 0.0097
35 PATHOLOGICAL GAMBLING 16 0.0096
36 PARKINSONIAN GAIT 6 0.0096
37 RAPID EYE MOVEMENTS SLEEP ABNORMAL 4 0.0094
38 APPLICATION SITE RASH 127 0.0092
39 URINE AMPHETAMINE POSITIVE 3 0.0091
40 SOFT TISSUE MASS 4 0.0087
41 FREEZING PHENOMENON 32 0.0086
42 RECALL PHENOMENON 7 0.0084
43 BLOOD CATECHOLAMINES INCREASED 1 0.0080
44 APPLICATION SITE SCAR 10 0.0080
45 ADMINISTRATION SITE RASH 1 0.0078
46 DROPPED HEAD SYNDROME 3 0.0076
47 ASYMPTOMATIC BACTERIURIA 1 0.0074
48 APPLICATION SITE NODULE 1 0.0073
49 DEJA VU 2 0.0073
50 ON AND OFF PHENOMENON 39 0.0070
51 APPLICATION SITE ERYTHEMA 183 0.0070
52 BINOCULAR EYE MOVEMENT DISORDER 2 0.0069
53 REDUCED FACIAL EXPRESSION 7 0.0069
54 GAMBLING 8 0.0069
55 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 6 0.0067
56 NUCHAL RIGIDITY 6 0.0066
57 APPLICATION SITE INFLAMMATION 9 0.0065
58 APPLICATION SITE DERMATITIS 6 0.0064
59 STOMA SITE HYPERGRANULATION 4 0.0063
60 ECHOLALIA 2 0.0063
61 PHAEOCHROMOCYTOMA 4 0.0061
62 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 3 0.0060
63 HALLUCINATION, TACTILE 4 0.0060
64 SALIVA DISCOLOURATION 2 0.0060
65 APPLICATION SITE DISCOLOURATION 24 0.0059
66 APPLICATION SITE INDURATION 1 0.0059
67 STOMA SITE REACTION 4 0.0058
68 MARITAL PROBLEM 3 0.0056
69 GAMBLING DISORDER 15 0.0055
70 APPLICATION SITE HAEMATOMA 1 0.0055
71 BURNING MOUTH SYNDROME 3 0.0053
72 APPLICATION SITE PRURITUS 120 0.0053
73 APPLICATION SITE INJURY 1 0.0053
74 STOMA SITE EXTRAVASATION 2 0.0052
75 APPLICATION SITE IRRITATION 62 0.0050
76 DEEP BRAIN STIMULATION 3 0.0050
77 DEVICE COLOUR ISSUE 2 0.0050
78 APPLICATION SITE HYPERSENSITIVITY 6 0.0049
79 MASKED FACIES 2 0.0049
80 POTENTIATING DRUG INTERACTION 16 0.0048
81 CAROTID ARTERY DISSECTION 2 0.0047
82 APPLICATION SITE EROSION 6 0.0047
83 BINGE EATING 5 0.0046
84 NITRITE URINE PRESENT 2 0.0046
85 DELUSION OF GRANDEUR 2 0.0045
86 PLEUROTHOTONUS 4 0.0044
87 COMPULSIVE SHOPPING 9 0.0044
88 ACUTE MOTOR-SENSORY AXONAL NEUROPATHY 1 0.0043
89 DRUG SCREEN FALSE POSITIVE 12 0.0043
90 SEXUALLY INAPPROPRIATE BEHAVIOUR 2 0.0043
91 STOMA SITE ERYTHEMA 8 0.0043
92 HYPERTENSIVE EMERGENCY 5 0.0042
93 LABILE BLOOD PRESSURE 5 0.0042
94 SLEEP ATTACKS 2 0.0042
95 APPLICATION SITE VESICLES 27 0.0042
96 APPLICATION SITE BLEEDING 1 0.0040
97 NECROTISING OESOPHAGITIS 2 0.0040
98 MULTIPLE DRUG THERAPY 3 0.0040
99 OESOPHAGEAL ULCER HAEMORRHAGE 2 0.0039
100 SCAPULA FRACTURE 2 0.0038
101 MEDICAL DEVICE CHANGE 2 0.0038
102 COMPULSIVE SEXUAL BEHAVIOUR 3 0.0037
103 STOMA SITE DISCHARGE 10 0.0036
104 POSTNASAL DRIP 2 0.0036
105 HALLUCINATION, VISUAL 75 0.0035
106 PARKINSON'S DISEASE 9 0.0035
107 SLEEP TALKING 6 0.0035
108 CHOREA 6 0.0035
109 DYSKINESIA 141 0.0035
110 IMPULSIVE BEHAVIOUR 13 0.0035
111 ORTHOSTATIC HYPERTENSION 2 0.0034
112 FOOD INTERACTION 6 0.0034
113 AKINESIA 7 0.0034
114 APPLICATION SITE SWELLING 16 0.0032
115 ASOCIAL BEHAVIOUR 1 0.0031
116 RESTING TREMOR 2 0.0031
117 ANOREXIA NERVOSA 1 0.0031
118 HYPERMAGNESAEMIA 2 0.0031
119 COMPULSIONS 2 0.0030
120 ARRHYTHMIC STORM 1 0.0030
121 MITRAL VALVE STENOSIS 2 0.0030
122 LIBIDO INCREASED 6 0.0030
123 CHOREOATHETOSIS 2 0.0029
124 BRADYKINESIA 17 0.0029
125 HALLUCINATIONS, MIXED 12 0.0029
126 POSTURE ABNORMAL 9 0.0028
127 SYMPTOM MASKED 2 0.0027
128 DELUSIONAL DISORDER, UNSPECIFIED TYPE 2 0.0027
129 DELUSION 40 0.0026
130 APPLICATION SITE HAEMORRHAGE 7 0.0026
131 SEROTONIN SYNDROME 49 0.0025
132 LABORATORY TEST INTERFERENCE 2 0.0025
133 ILLUSION 4 0.0024
134 APPLICATION SITE LACERATION 1 0.0024
135 PERSECUTORY DELUSION 6 0.0024
136 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 1 0.0024
137 MUSCLE RIGIDITY 28 0.0023
138 CRANIOFACIAL FRACTURE 2 0.0023
139 STOMA SITE INFECTION 3 0.0023
140 EXTRADURAL HAEMATOMA 3 0.0023
141 HALLUCINATION 171 0.0023
142 SENSATION OF PRESSURE 2 0.0023
143 FACIAL PARESIS 8 0.0023
144 OBSESSIVE THOUGHTS 4 0.0022
145 FIBROMA 2 0.0022
146 SUDDEN ONSET OF SLEEP 3 0.0022
147 STEREOTYPY 2 0.0021
148 CATAPLEXY 3 0.0021
149 APPLICATION SITE BURN 10 0.0020
150 APPLICATION SITE INFECTION 1 0.0020
151 BLADDER OBSTRUCTION 1 0.0019
152 APPLICATION SITE EXFOLIATION 8 0.0019
153 LIVEDO RETICULARIS 4 0.0019
154 COGWHEEL RIGIDITY 2 0.0019
155 ASPARTATE AMINOTRANSFERASE DECREASED 1 0.0019
156 YAWNING 5 0.0019
157 DISINHIBITION 3 0.0019
158 NEUROLEPTIC MALIGNANT SYNDROME 22 0.0019
159 PRODUCT RESIDUE PRESENT 10 0.0019
160 ORTHOSTATIC HYPOTENSION 32 0.0018
161 APPLICATION SITE DISCHARGE 2 0.0017
162 APPLICATION SITE PAIN 38 0.0017
163 HYPORESPONSIVE TO STIMULI 2 0.0017
164 APPLICATION SITE DISCOMFORT 3 0.0017
165 SKIN MASS 11 0.0016
166 PARKINSONISM 16 0.0016
167 HYPOMANIA 6 0.0016
168 TESTICULAR SWELLING 2 0.0016
169 HOSTILITY 4 0.0016
170 SUBCUTANEOUS HAEMATOMA 2 0.0016
171 REHABILITATION THERAPY 6 0.0015
172 PANIC DISORDER 6 0.0015
173 NASAL SEPTUM DEVIATION 3 0.0015
174 ANISOCYTOSIS 1 0.0015
175 PRODUCT ADHESION ISSUE 54 0.0015
176 HYPERPHAGIA 6 0.0015
177 AGORAPHOBIA 2 0.0015
178 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 1 0.0014
179 HYPERTENSIVE CRISIS 16 0.0014
180 DEVICE CONNECTION ISSUE 3 0.0014
181 APPLICATION SITE ULCER 1 0.0014
182 DERMATITIS CONTACT 16 0.0014
183 CEREBELLAR HAEMORRHAGE 2 0.0014
184 BITE 1 0.0014
185 ALANINE AMINOTRANSFERASE DECREASED 1 0.0014
186 APALLIC SYNDROME 1 0.0014
187 MUTISM 2 0.0014
188 JUDGEMENT IMPAIRED 2 0.0014
189 AUTONOMIC NERVOUS SYSTEM IMBALANCE 4 0.0014
190 AORTIC VALVE SCLEROSIS 1 0.0014
191 STOMA SITE PAIN 2 0.0014
192 GASTROINTESTINAL HYPOMOTILITY 3 0.0013
193 THERAPEUTIC PRODUCT EFFECT VARIABLE 5 0.0013
194 NONSPECIFIC REACTION 7 0.0013
195 INTESTINAL OPERATION 2 0.0013
196 DIABETES INSIPIDUS 3 0.0012
197 BASAL GANGLIA HAEMORRHAGE 1 0.0012
198 SHOULDER FRACTURE 2 0.0012
199 TONGUE ULCERATION 4 0.0012
200 APPLICATION SITE DRYNESS 4 0.0012
201 SEDATION COMPLICATION 3 0.0012
202 APTYALISM 1 0.0012
203 HYPOKINESIA 17 0.0012
204 CERVICAL VERTEBRAL FRACTURE 4 0.0012
205 WOUND INFECTION STAPHYLOCOCCAL 2 0.0012
206 THYROIDECTOMY 2 0.0012
207 ALCOHOL WITHDRAWAL SYNDROME 1 0.0011
208 DRUG SCREEN POSITIVE 9 0.0011
209 LOGORRHOEA 4 0.0011
210 PRODUCT CLEANING INADEQUATE 3 0.0011
211 AORTIC VALVE STENOSIS 2 0.0011
212 BRADYPNOEA 3 0.0011
213 PSYCHOMOTOR HYPERACTIVITY 18 0.0011
214 ALCOHOL USE 4 0.0011
215 MOTOR DYSFUNCTION 11 0.0011
216 LIVING IN RESIDENTIAL INSTITUTION 2 0.0011
217 BLOOD UREA ABNORMAL 1 0.0011
218 NARCOLEPSY 2 0.0011
219 PARANOIA 18 0.0010
220 ANTINUCLEAR ANTIBODY INCREASED 1 0.0010
221 OESOPHAGEAL ULCER 4 0.0010
222 CONVERSION DISORDER 2 0.0010
223 APPLICATION SITE BRUISE 1 0.0010
224 ATROPHY 2 0.0010
225 DEVICE POWER SOURCE ISSUE 3 0.0010
226 DROOLING 7 0.0010
227 SMALL FOR DATES BABY 5 0.0010
228 ANTISOCIAL BEHAVIOUR 1 0.0010
229 NORMOCHROMIC NORMOCYTIC ANAEMIA 3 0.0010
230 AUTONOMIC NEUROPATHY 1 0.0010
231 TENSION 6 0.0010
232 PSYCHOTIC SYMPTOM 2 0.0010
233 CHEST INJURY 2 0.0010
234 INTENTIONAL UNDERDOSE 7 0.0010
235 DEVICE MATERIAL ISSUE 2 0.0010
236 ELECTROENCEPHALOGRAM ABNORMAL 3 0.0009
237 DRUG EFFECT INCREASED 3 0.0009
238 DRUG EFFECT DECREASED 51 0.0009
239 TORTICOLLIS 2 0.0009
240 APPLICATION SITE PAPULES 1 0.0009
241 SCREAMING 6 0.0009
242 GASTROINTESTINAL MOTILITY DISORDER 5 0.0009
243 DYSTONIA 18 0.0009
244 REACTION TO DRUG EXCIPIENTS 2 0.0009
245 MANIA 15 0.0009
246 BIPOLAR I DISORDER 2 0.0009
247 AORTIC DILATATION 1 0.0009
248 NIGHTMARE 31 0.0009
249 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 2 0.0009
250 OBSESSIVE-COMPULSIVE DISORDER 7 0.0009
251 ABNORMAL DREAMS 24 0.0009
252 POLYMENORRHOEA 3 0.0009
253 DRUG INTERACTION 135 0.0009
254 DISTURBANCE IN SOCIAL BEHAVIOUR 2 0.0008
255 DECREASED INTEREST 5 0.0008
256 URINARY HESITATION 2 0.0008
257 WEIGHT ABNORMAL 2 0.0008
258 ABNORMAL BEHAVIOUR 33 0.0008
259 SELF ESTEEM DECREASED 2 0.0008
260 SLOW SPEECH 2 0.0008
261 BREATH ODOUR 2 0.0008
262 INFREQUENT BOWEL MOVEMENTS 2 0.0008
263 PRE-EXISTING CONDITION IMPROVED 5 0.0008
264 VENTRICULAR HYPERTROPHY 2 0.0008
265 ACIDOSIS 6 0.0008
266 APPLICATION SITE WARMTH 1 0.0008
267 THERAPEUTIC RESPONSE SHORTENED 26 0.0008
268 DEVICE OCCLUSION 11 0.0008
269 EUPHORIC MOOD 8 0.0008
270 GINGIVAL DISORDER 3 0.0008
271 AGITATION 57 0.0008
272 ADJUSTMENT DISORDER 1 0.0008
273 CHOKING 15 0.0008
274 APPLICATION SITE PARAESTHESIA 1 0.0008
275 SEXUAL DYSFUNCTION 9 0.0008
276 PRODUCT PACKAGING DIFFICULT TO OPEN 2 0.0008
277 WALKING AID USER 5 0.0008
278 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
279 CEREBRAL ATROPHY 3 0.0008
280 AREFLEXIA 2 0.0007
281 GAIT INABILITY 25 0.0007
282 ENURESIS 3 0.0007
283 NOCTURIA 9 0.0007
284 HIP SURGERY 4 0.0007
285 CLUMSINESS 2 0.0007
286 AKATHISIA 10 0.0007
287 CONFUSIONAL STATE 118 0.0007
288 TREMOR 121 0.0007
289 TENOSYNOVITIS 2 0.0007
290 CHOLECYSTITIS INFECTIVE 2 0.0007
291 IRRITABILITY 43 0.0007
292 DRUG TOLERANCE DECREASED 2 0.0007
293 SKIN HYPERTROPHY 2 0.0007
294 PSYCHOTIC DISORDER 21 0.0007
295 INSOMNIA 189 0.0007
296 EJACULATION DISORDER 2 0.0007
297 MIDDLE INSOMNIA 13 0.0007
298 HYPOGLYCAEMIC COMA 2 0.0007
299 DYSARTHRIA 26 0.0007
300 HAEMOTHORAX 2 0.0007
301 IMMOBILE 3 0.0007
302 GASTROINTESTINAL NECROSIS 2 0.0007
303 MAJOR DEPRESSION 5 0.0007
304 INITIAL INSOMNIA 7 0.0007
305 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 7 0.0007
306 ENERGY INCREASED 4 0.0007
307 ADHESION 1 0.0007
308 INCONTINENCE 7 0.0007
309 DRUG EFFECT DELAYED 3 0.0007
310 ASTIGMATISM 1 0.0007
311 AGE-RELATED MACULAR DEGENERATION 1 0.0007
312 SUICIDAL IDEATION 60 0.0007
313 MOVEMENT DISORDER 21 0.0007
314 SCOLIOSIS 4 0.0006
315 SKIN ABRASION 3 0.0006
316 HYPOCALCAEMIA 12 0.0006
317 NON-CARDIAC CHEST PAIN 2 0.0006
318 BLADDER PAIN 2 0.0006
319 ANALGESIC DRUG LEVEL INCREASED 1 0.0006
320 BLADDER CANCER STAGE II 1 0.0006
321 PRESCRIBED OVERDOSE 12 0.0006
322 AGGRESSION 31 0.0006
323 APATHY 9 0.0006
324 MICTURITION URGENCY 7 0.0006
325 SEDATION 16 0.0006
326 INJECTION SITE INFECTION 2 0.0006
327 SALIVARY HYPERSECRETION 6 0.0006
328 DRUG TOLERANCE 3 0.0006
329 BALANCE DISORDER 51 0.0006
330 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
331 CRYING 21 0.0006
332 TACHYPHRENIA 2 0.0006
333 FEELING JITTERY 11 0.0006
334 HYPOPNOEA 2 0.0006
335 COORDINATION ABNORMAL 8 0.0006
336 HANGOVER 2 0.0006
337 DEPRESSION 128 0.0006
338 DEVICE PLACEMENT ISSUE 2 0.0006
339 COGNITIVE DISORDER 26 0.0006
340 DEVICE KINK 2 0.0005
341 PANIC ATTACK 20 0.0005
342 WITHDRAWAL SYNDROME 23 0.0005
343 INTESTINAL ISCHAEMIA 3 0.0005
344 ANOREXIA 7 0.0005
345 DEMENTIA 15 0.0005
346 MUSCULOSKELETAL STIFFNESS 47 0.0005
347 ANGER 18 0.0005
348 SPUTUM DISCOLOURED 5 0.0005
349 SOMNOLENCE 106 0.0005
350 HYPERSOMNIA 15 0.0005
351 CLAVICLE FRACTURE 2 0.0005
352 PNEUMONIA ASPIRATION 13 0.0005
353 HYPERHIDROSIS 67 0.0005
354 DRY MOUTH 42 0.0005
355 FAECES HARD 2 0.0005
356 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
357 AFFECTIVE DISORDER 4 0.0005
358 HOSPICE CARE 5 0.0005
359 MYOCLONUS 6 0.0005
360 HYPOMAGNESAEMIA 7 0.0005
361 PRESCRIBED UNDERDOSE 10 0.0005
362 SKIN REACTION 7 0.0005
363 MUSCLE DISORDER 4 0.0005
364 SUBARACHNOID HAEMORRHAGE 5 0.0005
365 ARTHRITIS BACTERIAL 2 0.0005
366 SELF-MEDICATION 2 0.0005
367 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
368 FEAR 13 0.0005
369 SOCIAL PROBLEM 2 0.0005
370 ILEUS 6 0.0005
371 SUICIDAL BEHAVIOUR 2 0.0005
372 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
373 TRANSIENT ISCHAEMIC ATTACK 16 0.0005
374 SLEEP APNOEA SYNDROME 9 0.0005
375 ANAEMIA MACROCYTIC 1 0.0005
376 SHOULDER OPERATION 2 0.0005
377 GALACTORRHOEA 3 0.0005
378 HIP FRACTURE 15 0.0005
379 ABNORMAL SENSATION IN EYE 2 0.0005
380 TENSION HEADACHE 2 0.0005
381 APPLICATION SITE SCAB 1 0.0005
382 DIPLOPIA 12 0.0005
383 BIPOLAR DISORDER 5 0.0005
384 BRADYPHRENIA 3 0.0005
385 PRODUCT PRESCRIBING ISSUE 10 0.0005
386 BLOOD PRESSURE FLUCTUATION 11 0.0005
387 SOMNAMBULISM 3 0.0005
388 PRODUCT FORMULATION ISSUE 3 0.0005
389 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 4 0.0005
390 WHEELCHAIR USER 2 0.0004
391 ANXIETY 128 0.0004
392 ANAL INCONTINENCE 4 0.0004
393 FALL 147 0.0004
394 VASCULAR DEVICE INFECTION 2 0.0004
395 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
396 RESTLESS LEGS SYNDROME 8 0.0004
397 RESTLESSNESS 16 0.0004
398 DEPRESSED MOOD 23 0.0004
399 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
400 GRAND MAL CONVULSION 4 0.0004
401 DELIRIUM 15 0.0004
402 PERSONALITY CHANGE 4 0.0004
403 FEELING OF DESPAIR 2 0.0004
404 PERFORMANCE STATUS DECREASED 2 0.0004
405 LACERATION 4 0.0004
406 MULTIPLE ORGAN DYSFUNCTION SYNDROME 12 0.0004
407 HAND FRACTURE 3 0.0004
408 ATAXIA 5 0.0004
409 ENDOMETRIOSIS 2 0.0004
410 MACULAR DEGENERATION 5 0.0004
411 PANIC REACTION 3 0.0004
412 APHAGIA 2 0.0004
413 HEAD INJURY 13 0.0004
414 OEDEMA PERIPHERAL 50 0.0004
415 THROAT TIGHTNESS 11 0.0004
416 PSYCHIATRIC SYMPTOM 3 0.0004
417 HYPERCALCAEMIA 5 0.0004
418 MULTIPLE DRUG OVERDOSE 2 0.0004
419 NERVOUSNESS 21 0.0004
420 BODY TEMPERATURE INCREASED 8 0.0004
421 BOWEL MOVEMENT IRREGULARITY 3 0.0004
422 TEMPERATURE INTOLERANCE 4 0.0004
423 TRISMUS 2 0.0004
424 STOMACH DISCOMFORT 2 0.0004
425 WRONG TECHNIQUE IN DRUG USAGE PROCESS 14 0.0004
426 TREATMENT NONCOMPLIANCE 21 0.0004
427 BEDRIDDEN 5 0.0004
428 BLOOD PRESSURE INCREASED 58 0.0004
429 HALLUCINATION, AUDITORY 6 0.0004
430 LOW BIRTH WEIGHT BABY 3 0.0004
431 NYSTAGMUS 2 0.0004
432 BLOOD PRESSURE DECREASED 25 0.0004
433 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 18 0.0004
434 ANAESTHETIC COMPLICATION 1 0.0004
435 RHINITIS 3 0.0004
436 MUSCLE TIGHTNESS 6 0.0004
437 BACK DISORDER 6 0.0004
438 ABDOMINAL RIGIDITY 1 0.0004
439 ANORGASMIA 1 0.0004
440 DECUBITUS ULCER 3 0.0004
441 TACHYPNOEA 5 0.0004
442 IMPAIRED GASTRIC EMPTYING 5 0.0004
443 ENCEPHALOPATHY 9 0.0004
444 POST PROCEDURAL COMPLICATION 7 0.0004
445 SUICIDE ATTEMPT 22 0.0004
446 CHOKING SENSATION 2 0.0004
447 ACUTE CORONARY SYNDROME 3 0.0004
448 DENTAL CARIES 4 0.0004
449 MENTAL STATUS CHANGES 10 0.0004
450 ORAL DISCOMFORT 5 0.0004
451 DYSPHAGIA 34 0.0004
452 MEMORY IMPAIRMENT 49 0.0004
453 SENSATION OF FOREIGN BODY 3 0.0004
454 DYSURIA 13 0.0004
455 HYPOPHAGIA 9 0.0004
456 GENERALISED ERYTHEMA 2 0.0004
457 UPPER LIMB FRACTURE 7 0.0004
458 GAIT DISTURBANCE 67 0.0003
459 VISUAL DISTURBANCE 2 0.0003
460 MUSCLE TWITCHING 8 0.0003
461 SOCIAL AVOIDANT BEHAVIOUR 2 0.0003
462 ANOSMIA 5 0.0003
463 DEVICE DISLOCATION 15 0.0003
464 DEVICE USE ISSUE 6 0.0003
465 HYPOVOLAEMIA 2 0.0003
466 DIZZINESS 170 0.0003
467 RIB FRACTURE 7 0.0003
468 SINUS HEADACHE 2 0.0003
469 CARDIAC PACEMAKER INSERTION 2 0.0003
470 THERAPY NON-RESPONDER 15 0.0003
471 MOOD ALTERED 9 0.0003
472 ECONOMIC PROBLEM 5 0.0003
473 SCHIZOPHRENIA 4 0.0003
474 FOETAL GROWTH RESTRICTION 2 0.0003
475 DISORIENTATION 13 0.0003
476 UROSEPSIS 3 0.0003
477 POOR QUALITY SLEEP 7 0.0003
478 SMALL INTESTINAL OBSTRUCTION 4 0.0003
479 SPEECH DISORDER 17 0.0003
480 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 2 0.0003
481 DEVICE ISSUE 29 0.0003
482 EXTRAPYRAMIDAL DISORDER 8 0.0003
483 THINKING ABNORMAL 6 0.0003
484 AGEUSIA 8 0.0003
485 INFUSION SITE SWELLING 2 0.0003
486 PRODUCT PACKAGING ISSUE 3 0.0003
487 DISTURBANCE IN ATTENTION 17 0.0003
488 INCREASED APPETITE 6 0.0003
489 MOOD SWINGS 10 0.0003
490 THERAPEUTIC RESPONSE UNEXPECTED 14 0.0003
491 AFFECT LABILITY 3 0.0003
492 DIZZINESS POSTURAL 3 0.0003
493 DYSSTASIA 9 0.0003
494 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
495 COELIAC DISEASE 3 0.0003
496 JOINT STIFFNESS 8 0.0003
497 DYSGRAPHIA 2 0.0003
498 ANXIETY DISORDER 1 0.0003
499 QUALITY OF LIFE DECREASED 4 0.0003
500 PRODUCT PHYSICAL ISSUE 6 0.0003
501 PRODUCT LABEL ISSUE 2 0.0003
502 DISEASE RECURRENCE 14 0.0003
503 CONDITION AGGRAVATED 89 0.0003
504 RESPIRATION ABNORMAL 2 0.0003
505 RHABDOMYOLYSIS 12 0.0003
506 POLLAKIURIA 12 0.0003
507 FORMICATION 2 0.0003
508 AORTIC STENOSIS 1 0.0003
509 EXTRASYSTOLES 2 0.0003
510 CARPAL TUNNEL SYNDROME 4 0.0003
511 CYSTITIS 9 0.0003
512 EATING DISORDER 6 0.0003
513 FEAR OF INJECTION 2 0.0003
514 APPENDICECTOMY 1 0.0003
515 PARALYSIS 4 0.0003
516 HYPOTENSION 56 0.0003
517 UNEVALUABLE EVENT 21 0.0003
518 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
519 FEELING ABNORMAL 66 0.0003
520 WOUND INFECTION 3 0.0003
521 ORAL DISORDER 2 0.0003
522 ERECTILE DYSFUNCTION 7 0.0003
523 DEVICE BREAKAGE 11 0.0003
524 EXPIRED PRODUCT ADMINISTERED 9 0.0003
525 RASH GENERALISED 7 0.0003
526 FEELING DRUNK 2 0.0003
527 NECK PAIN 15 0.0003
528 GENERAL SYMPTOM 2 0.0003
529 HYPONATRAEMIA 15 0.0003
530 BLOOD SODIUM DECREASED 5 0.0003
531 APHASIA 8 0.0003
532 PALPITATIONS 31 0.0003
533 MUSCULOSKELETAL DISORDER 5 0.0003
534 CONVULSION 15 0.0003
535 HYPERTHERMIA 2 0.0003
536 HIP ARTHROPLASTY 4 0.0003
537 GLAUCOMA 5 0.0003
538 THYROID DISORDER 4 0.0003
539 CONCUSSION 2 0.0003
540 PELVIC FRACTURE 2 0.0003
541 SPINAL PAIN 3 0.0003
542 MENTAL DISORDER 11 0.0003
543 CONSTIPATION 55 0.0003
544 PRODUCT PRESCRIBING ERROR 6 0.0003
545 RENAL CYST 2 0.0003
546 MOBILITY DECREASED 18 0.0003
547 SYNCOPE 25 0.0002
548 DRUG INEFFECTIVE 329 0.0002
549 BLEPHARITIS 1 0.0002
550 SENSORY LOSS 2 0.0002
551 DRUG EFFECT INCOMPLETE 9 0.0002
552 MENTAL IMPAIRMENT 6 0.0002
553 PRODUCT ADMINISTRATION ERROR 5 0.0002
554 THERAPEUTIC RESPONSE DECREASED 15 0.0002
555 ASPHYXIA 2 0.0002
556 ABNORMAL FAECES 2 0.0002
557 HICCUPS 2 0.0002
558 ANAPHYLACTOID REACTION 1 0.0002
559 ABASIA 6 0.0002
560 GENERALISED OEDEMA 3 0.0002
561 SPINAL COMPRESSION FRACTURE 2 0.0002
562 TOOTH EXTRACTION 3 0.0002
563 DRUG ABUSE 20 0.0002
564 INTENTIONAL PRODUCT MISUSE 21 0.0002
565 URINARY RETENTION 8 0.0002
566 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 17 0.0002
567 DERMATITIS ALLERGIC 3 0.0002
568 CELLULITIS 12 0.0002
569 ACUTE MYOCARDIAL INFARCTION 7 0.0002
570 INFUSION SITE ERYTHEMA 2 0.0002
571 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 48 0.0002
572 TACHYCARDIA 21 0.0002
573 AORTIC VALVE INCOMPETENCE 1 0.0002
574 ABSCESS LIMB 1 0.0002
575 INTENTIONAL OVERDOSE 15 0.0002
576 MYDRIASIS 3 0.0002
577 MUSCULOSKELETAL DISCOMFORT 4 0.0002
578 MYOPATHY 2 0.0002
579 PRURITUS GENERALISED 5 0.0002
580 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
581 HAND DEFORMITY 3 0.0002
582 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
583 BLOOD CALCIUM INCREASED 2 0.0002
584 ADVERSE EVENT 21 0.0002
585 TOOTH DISORDER 5 0.0002
586 FACIAL PAIN 2 0.0002
587 MALIGNANT MELANOMA 3 0.0002
588 GASTROINTESTINAL INFECTION 2 0.0002
589 CHROMATURIA 5 0.0002
590 DRUG TOXICITY 3 0.0002
591 MUSCULAR WEAKNESS 25 0.0002
592 ABDOMINAL HERNIA 1 0.0002
593 DEHYDRATION 29 0.0002
594 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
595 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
596 HUNGER 3 0.0002
597 DEFORMITY 2 0.0002
598 SLEEP DISORDER 15 0.0002
599 URINARY TRACT INFECTION 36 0.0002
600 POISONING DELIBERATE 2 0.0002
601 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
602 ACCIDENTAL UNDERDOSE 3 0.0002
603 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
604 PERIPHERAL SWELLING 32 0.0002
605 PHARYNGEAL SWELLING 2 0.0002
606 RENAL TUBULAR NECROSIS 2 0.0002
607 CARDIOMYOPATHY 3 0.0002
608 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
609 LIGAMENT SPRAIN 2 0.0002
610 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
611 HEART RATE INCREASED 20 0.0002
612 ABDOMINAL TENDERNESS 1 0.0002
613 RHINORRHOEA 13 0.0002
614 PREGNANCY 4 0.0002
615 HYPERKALAEMIA 7 0.0002
616 INTENTIONAL SELF-INJURY 4 0.0002
617 HYPOTHERMIA 2 0.0002
618 DRY THROAT 2 0.0002
619 SKIN IRRITATION 9 0.0002
620 SKIN DISCOLOURATION 9 0.0002
621 PHARYNGEAL OEDEMA 3 0.0002
622 EAR DISCOMFORT 2 0.0002
623 DRUG RESISTANCE 5 0.0002
624 ELECTROCARDIOGRAM QT PROLONGED 7 0.0002
625 DRUG WITHDRAWAL SYNDROME 17 0.0002
626 VENTRICULAR EXTRASYSTOLES 2 0.0002
627 SWOLLEN TONGUE 6 0.0002
628 PETECHIAE 2 0.0002
629 LETHARGY 11 0.0002
630 WEIGHT DECREASED 53 0.0002
631 BLOOD LACTIC ACID INCREASED 1 0.0002
632 DECREASED APPETITE 44 0.0002
633 JOINT DISLOCATION 2 0.0002
634 PNEUMOTHORAX 3 0.0002
635 SUDDEN DEATH 2 0.0002
636 HYPERTENSION 40 0.0002
637 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
638 SENSORY DISTURBANCE 3 0.0002
639 MUSCLE SPASMS 34 0.0002
640 BEHAVIOUR DISORDER 1 0.0002
641 SKIN LACERATION 2 0.0002
642 PRODUCT DOSE OMISSION 12 0.0002
643 PRODUCT DISPENSING ERROR 4 0.0002
644 DRUG LEVEL INCREASED 3 0.0002
645 RESPIRATORY DISTRESS 5 0.0002
646 FOOT DEFORMITY 2 0.0002
647 FEELING COLD 5 0.0002
648 INTESTINAL PERFORATION 2 0.0002
649 OCULAR DISCOMFORT 2 0.0002
650 UNDERDOSE 13 0.0002
651 TOXICITY TO VARIOUS AGENTS 30 0.0002
652 BLOOD CALCIUM DECREASED 2 0.0002
653 TARDIVE DYSKINESIA 5 0.0002
654 HEART RATE IRREGULAR 4 0.0002
655 PAIN IN JAW 5 0.0002
656 IMPAIRED DRIVING ABILITY 2 0.0002
657 INTERNAL HAEMORRHAGE 2 0.0002
658 WEIGHT INCREASED 39 0.0002
659 TINNITUS 8 0.0002
660 LOSS OF CONSCIOUSNESS 22 0.0002
661 SPLENOMEGALY 2 0.0002
662 HEADACHE 107 0.0002
663 COLD SWEAT 3 0.0002
664 ASTHENIA 64 0.0002
665 AMNESIA 11 0.0002
666 URINARY INCONTINENCE 5 0.0002
667 THIRST 3 0.0002
668 RESPIRATORY DISORDER 5 0.0002
669 POLYNEUROPATHY 2 0.0002
670 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
671 C-REACTIVE PROTEIN INCREASED 6 0.0002
672 NEURALGIA 4 0.0002
673 FEELING HOT 10 0.0002
674 MUSCLE SPASTICITY 2 0.0002
675 SPINAL OPERATION 2 0.0002
676 TENDON RUPTURE 2 0.0002
677 DEVICE LEAKAGE 7 0.0002
678 PHARYNGITIS 2 0.0002
679 CYST 2 0.0002
680 SECRETION DISCHARGE 2 0.0002
681 PHOTOPHOBIA 3 0.0002
682 BLEPHAROSPASM 1 0.0002
683 BRAIN OEDEMA 2 0.0002
684 MIGRAINE 15 0.0002
685 DRUG PRESCRIBING ERROR 3 0.0002
686 COMPLETED SUICIDE 13 0.0002
687 UNRESPONSIVE TO STIMULI 4 0.0002
688 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 11 0.0002
689 HAEMATOMA 4 0.0002
690 HYPOAESTHESIA 23 0.0002
691 NASAL CONGESTION 9 0.0002
692 NEPHROLITHIASIS 7 0.0002
693 CHOLELITHIASIS 5 0.0002
694 ANHEDONIA 4 0.0002
695 GASTRITIS 4 0.0002
696 DISABILITY 3 0.0002
697 SARS-COV-2 TEST POSITIVE 2 0.0002
698 HAEMATOCRIT DECREASED 3 0.0002
699 BLOOD PRESSURE ABNORMAL 3 0.0002
700 SPINAL FRACTURE 3 0.0001
701 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
702 JOINT RANGE OF MOTION DECREASED 2 0.0001
703 FATIGUE 115 0.0001
704 COMA 7 0.0001
705 ABNORMAL LOSS OF WEIGHT 1 0.0001
706 PERIPHERAL COLDNESS 2 0.0001
707 CONTUSION 14 0.0001
708 RESPIRATORY ARREST 4 0.0001
709 TOOTH LOSS 3 0.0001
710 PROCEDURAL PAIN 4 0.0001
711 ROAD TRAFFIC ACCIDENT 6 0.0001
712 APHONIA 2 0.0001
713 PRODUCT DOSE OMISSION ISSUE 42 0.0001
714 NAUSEA 113 0.0001
715 MOUTH ULCERATION 3 0.0001
716 RENAL FAILURE ACUTE 6 0.0001
717 JOINT INJURY 3 0.0001
718 CHEST PAIN 26 0.0001
719 IMPAIRED WORK ABILITY 3 0.0001
720 HYPERSENSITIVITY 26 0.0001
721 ANGINA PECTORIS 4 0.0001
722 COUGH 39 0.0001
723 HYPERGLYCAEMIA 5 0.0001
724 DYSPHONIA 8 0.0001
725 CHILLS 16 0.0001
726 DEVICE DIFFICULT TO USE 9 0.0001
727 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
728 RASH MACULO-PAPULAR 3 0.0001
729 CATARACT 8 0.0001
730 GLOSSODYNIA 3 0.0001
731 PULMONARY OEDEMA 6 0.0001
732 HAEMORRHAGE 14 0.0001
733 THROAT IRRITATION 6 0.0001
734 MUSCULOSKELETAL PAIN 7 0.0001
735 HYPOAESTHESIA ORAL 2 0.0001
736 LACRIMATION INCREASED 4 0.0001
737 DRUG ADMINISTRATION ERROR 4 0.0001
738 EMOTIONAL DISORDER 4 0.0001
739 LIMB DISCOMFORT 4 0.0001
740 FEMUR FRACTURE 4 0.0001
741 EJECTION FRACTION DECREASED 2 0.0001
742 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 6 0.0001
743 BRAIN FOG 2 0.0001
744 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
745 CYANOSIS 2 0.0001
746 PRODUCT USE COMPLAINT 2 0.0001
747 CHEST DISCOMFORT 13 0.0001
748 MEDICATION ERROR 7 0.0001
749 RESPIRATORY TRACT CONGESTION 2 0.0001
750 ATRIAL FLUTTER 1 0.0001
751 PRODUCT QUALITY ISSUE 17 0.0001
752 METABOLIC ACIDOSIS 4 0.0001
753 DRUG INTOLERANCE 12 0.0001
754 NIGHT SWEATS 4 0.0001
755 RASH 54 0.0001
756 RESPIRATORY FAILURE 9 0.0001
757 PRESYNCOPE 3 0.0001
758 ADVERSE DRUG REACTION 11 0.0001
759 GENERAL PHYSICAL HEALTH DETERIORATION 14 0.0001
760 MALAISE 53 0.0001
761 BACK PAIN 28 0.0001
762 LIP SWELLING 4 0.0001
763 COAGULOPATHY 2 0.0001
764 CARDIO-RESPIRATORY ARREST 5 0.0001
765 BLOOD UREA INCREASED 2 0.0001
766 URTICARIA 20 0.0001
767 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
768 INCORRECT DOSE ADMINISTERED 27 0.0001
769 MYALGIA 20 0.0001
770 ACUTE KIDNEY INJURY 18 0.0001
771 CIRCULATORY COLLAPSE 2 0.0001
772 SCAR 2 0.0001
773 ERYTHEMA 24 0.0001
774 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
775 PHARMACEUTICAL PRODUCT COMPLAINT 3 0.0001
776 DEVICE DEFECTIVE 2 0.0001
777 DEVICE USE ERROR 4 0.0001
778 INCORRECT DOSE ADMINISTERED BY DEVICE 3 0.0001
779 PARAESTHESIA 18 0.0001
780 INTENTIONAL PRODUCT USE ISSUE 10 0.0001
781 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
782 ABDOMINAL PAIN 26 0.0001
783 PRODUCT USE ISSUE 21 0.0001
784 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
785 OVERDOSE 24 0.0001
786 HOSPITALISATION 17 0.0001
787 LEUKOCYTOSIS 2 0.0001
788 TOOTHACHE 2 0.0001
789 DEVICE DELIVERY SYSTEM ISSUE 3 0.0001
790 JOINT SWELLING 13 0.0001
791 AGRANULOCYTOSIS 2 0.0001
792 HEPATIC STEATOSIS 2 0.0001
793 APPENDICITIS 1 0.0001
794 ARTERIOSCLEROSIS 1 0.0001
795 ABORTION INDUCED 1 0.0001
796 INTESTINAL OBSTRUCTION 4 0.0001
797 FLATULENCE 6 0.0001
798 BLOOD URINE PRESENT 2 0.0001
799 PROTEINURIA 2 0.0001
800 PRODUCT SUBSTITUTION ISSUE 6 0.0001
801 ATELECTASIS 1 0.0001
802 HERNIA 2 0.0001
803 LIVER FUNCTION TEST ABNORMAL 3 0.0001
804 ABDOMINAL PAIN UPPER 21 0.0001
805 KIDNEY INFECTION 2 0.0001
806 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
807 SINUS DISORDER 2 0.0001
808 BLADDER DISORDER 1 0.0001
809 GASTROINTESTINAL DISORDER 9 0.0001
810 HEPATIC FAILURE 3 0.0001
811 EMOTIONAL DISTRESS 12 0.0001
812 CORONARY ARTERY DISEASE 3 0.0001
813 ILL-DEFINED DISORDER 6 0.0001
814 VERTIGO 6 0.0001
815 EPILEPSY 3 0.0001
816 THERAPY CESSATION 5 0.0001
817 INFLUENZA LIKE ILLNESS 8 0.0001
818 ILLNESS 10 0.0001
819 INTENTIONAL DRUG MISUSE 2 0.0001
820 RENAL IMPAIRMENT 8 0.0001
821 OFF LABEL USE 83 0.0001
822 VISION BLURRED 13 0.0001
823 CEREBROVASCULAR ACCIDENT 16 0.0001
824 OSTEOARTHRITIS 4 0.0001
825 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 17 0.0001
826 RECTAL HAEMORRHAGE 4 0.0001
827 DEATH 80 0.0001
828 FAECES DISCOLOURED 2 0.0001
829 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
830 ASPIRATION 1 0.0001
831 VISUAL ACUITY REDUCED 3 0.0001
832 DYSPNOEA 51 0.0001
833 PNEUMONIA 29 0.0001
834 ORAL PAIN 2 0.0001
835 SNEEZING 2 0.0001
836 SEIZURE 10 0.0001
837 PERICARDIAL EFFUSION 2 0.0001
838 INJURY 6 0.0001
839 BLOOD IRON DECREASED 1 0.0001
840 CEREBRAL HAEMORRHAGE 3 0.0001
841 ABDOMINAL DISCOMFORT 14 0.0001
842 LOCALISED INFECTION 2 0.0001
843 ACCIDENTAL OVERDOSE 3 0.0001
844 CEREBRAL INFARCTION 2 0.0001
845 PAIN IN EXTREMITY 24 0.0001
846 PRODUCT USE IN UNAPPROVED INDICATION 20 0.0001
847 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
848 DRY EYE 4 0.0001
849 HAEMATEMESIS 2 0.0001
850 HEPATITIS 2 0.0001
851 PAIN 48 0.0001
852 ABDOMINAL DISTENSION 8 0.0001
853 DEAFNESS 2 0.0001
854 ADVERSE REACTION 1 0.0001
855 EAR INFECTION 2 0.0001
856 SWELLING 7 0.0001
857 CARDIAC FAILURE 6 0.0001
858 THROMBOSIS 6 0.0001
859 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
860 VOMITING 35 0.0001
861 OEDEMA 4 0.0001
862 BLINDNESS 3 0.0001
863 SKIN LESION 2 0.0001
864 PRURITUS 28 0.0001
865 CARDIAC ARREST 6 0.0001
866 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
867 BLINDNESS UNILATERAL 1 0.0001
868 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
869 INTENTIONAL DOSE OMISSION 2 0.0001
870 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
871 RED BLOOD CELL COUNT DECREASED 2 0.0001
872 HYPOACUSIS 3 0.0001
873 EYE IRRITATION 4 0.0001
874 SURGERY 4 0.0001
875 WHEEZING 4 0.0001
876 DYSGEUSIA 5 0.0001
877 BLOOD POTASSIUM DECREASED 2 0.0001
878 PREMATURE BABY 2 0.0001
879 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
880 PLEURAL EFFUSION 4 0.0001
881 DISCOMFORT 4 0.0001
882 HYPOKALAEMIA 3 0.0001
883 ARTHRALGIA 27 0.0001
884 OROPHARYNGEAL PAIN 6 0.0001
885 ANKLE FRACTURE 1 0.0001
886 BASAL CELL CARCINOMA 1 0.0001
887 NERVOUS SYSTEM DISORDER 2 0.0001
888 ARTHRITIS 5 0.0001
889 NEUROPATHY PERIPHERAL 6 0.0001
890 PRODUCTIVE COUGH 3 0.0001
891 SEPSIS 7 0.0001
892 BLOOD GLUCOSE DECREASED 3 0.0001
893 INFECTION 9 0.0001
894 ATRIAL FIBRILLATION 6 0.0001
895 BLOOD POTASSIUM INCREASED 1 0.0001
896 FOETAL EXPOSURE DURING PREGNANCY 5 0.0001
897 SWELLING FACE 4 0.0001
898 BLOOD CREATININE INCREASED 4 0.0001
899 ALOPECIA 12 0.0001
900 DYSPEPSIA 6 0.0001
901 EYE DISORDER 2 0.0001
902 STAPHYLOCOCCAL INFECTION 2 0.0001
903 INFUSION RELATED REACTION 4 0.0001
904 VIRAL INFECTION 2 0.0001
905 GASTROINTESTINAL HAEMORRHAGE 5 0.0001
906 TYPE 2 DIABETES MELLITUS 2 0.0001
907 FLUID RETENTION 3 0.0001
908 SINUSITIS 6 0.0001
909 HAEMATURIA 2 0.0001
910 GASTRIC DISORDER 2 0.0001
911 INJECTION SITE REACTION 4 0.0001
912 MYOCARDIAL INFARCTION 10 0.0001
913 RASH MACULAR 2 0.0001
914 PRODUCT STORAGE ERROR 5 0.0001
915 AMENORRHOEA 1 0.0001
916 HEART RATE DECREASED 2 0.0001
917 HYPOXIA 2 0.0001
918 BRADYCARDIA 3 0.0001
919 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
920 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
921 THERAPY INTERRUPTED 4 0.0001
922 NO ADVERSE EVENT 10 0.0001
923 DRUG DOSE OMISSION 9 0.0001
924 ANAPHYLACTIC REACTION 3 0.0001
925 BRONCHITIS 4 0.0001
926 BACTERIAL INFECTION 1 0.0001
927 CARDIAC DISORDER 5 0.0001
928 BLISTER 3 0.0001
929 DYSPNOEA EXERTIONAL 2 0.0001
930 RENAL FAILURE 7 0.0001
931 PULMONARY EMBOLISM 5 0.0001
932 HERPES ZOSTER 3 0.0001
933 ACUTE RESPIRATORY FAILURE 1 0.0001
934 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
935 BONE PAIN 3 0.0001
936 DISEASE PROGRESSION 6 0.0001
937 PSORIATIC ARTHROPATHY 2 0.0000
938 PYREXIA 17 0.0000
939 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
940 NASOPHARYNGITIS 9 0.0000
941 HAEMOGLOBIN DECREASED 5 0.0000
942 DEEP VEIN THROMBOSIS 3 0.0000
943 SEPTIC SHOCK 2 0.0000
944 ANGIOEDEMA 2 0.0000
945 LIVER DISORDER 2 0.0000
946 INFLUENZA 5 0.0000
947 DRUG DEPENDENCE 7 0.0000
948 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
949 RENAL DISORDER 2 0.0000
950 BURNING SENSATION 3 0.0000
951 ARRHYTHMIA 2 0.0000
952 OCULAR HYPERAEMIA 2 0.0000
953 SKIN BURNING SENSATION 3 0.0000
954 HYPOGLYCAEMIA 2 0.0000
955 LUNG DISORDER 2 0.0000
956 EPISTAXIS 3 0.0000
957 HOT FLUSH 3 0.0000
958 ABDOMINAL PAIN LOWER 1 0.0000
959 DIABETES MELLITUS 3 0.0000
960 FLUSHING 4 0.0000
961 DIARRHOEA 25 0.0000
962 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
963 PANCREATITIS 2 0.0000
964 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
965 PLATELET COUNT DECREASED 4 0.0000
966 PROSTATE CANCER 3 0.0000
967 BLOOD BILIRUBIN INCREASED 1 0.0000
968 RASH PRURITIC 2 0.0000
969 HAEMATOCHEZIA 2 0.0000
970 ARTHROPATHY 2 0.0000
971 SKIN EXFOLIATION 3 0.0000
972 ASTHMA 4 0.0000
973 STOMATITIS 2 0.0000
974 INJECTION SITE PAIN 10 0.0000
975 VISUAL IMPAIRMENT 4 0.0000
976 INJECTION SITE ERYTHEMA 4 0.0000
977 EXPOSURE DURING PREGNANCY 2 0.0000
978 ANAEMIA 6 0.0000
979 PSORIASIS 4 0.0000
980 COVID-19 5 0.0000
981 THROMBOCYTOPENIA 3 0.0000
982 INJECTION SITE SWELLING 2 0.0000
983 INJECTION SITE HAEMORRHAGE 2 0.0000
984 CARDIAC FAILURE CONGESTIVE 2 0.0000
985 TREATMENT FAILURE 2 0.0000
986 DRY SKIN 3 0.0000
987 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
988 RHEUMATOID ARTHRITIS 2 0.0000
989 BLOOD GLUCOSE INCREASED 3 0.0000
990 ACNE 1 0.0000
991 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000